Equities

Spire Healthcare Group PLC

Spire Healthcare Group PLC

Actions
Health CareHealth Care Providers
  • Price (GBX)217.00
  • Today's Change-3.00 / -1.36%
  • Shares traded422.37k
  • 1 Year change-2.69%
  • Beta1.5128
Data delayed at least 20 minutes, as of Nov 12 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Spire Healthcare Group PLC grew revenues 13.72% from 1.20bn to 1.36bn while net income improved 217.44% from 8.60m to 27.30m.
Gross margin45.45%
Net profit margin2.12%
Operating margin9.13%
Return on assets1.37%
Return on equity4.04%
Return on investment1.59%
More ▼

Cash flow in GBPView more

In 2023, cash reserves at Spire Healthcare Group PLC fell by 24.60m. However, the company earned 215.50m from its operations for a Cash Flow Margin of 15.86%. In addition the company used 157.20m on investing activities and also paid 82.90m in financing cash flows.
Cash flow per share0.3371
Price/Cash flow per share6.35
Book value per share1.83
Tangible book value per share0.7475
More ▼

Balance sheet in GBPView more

Spire Healthcare Group PLC has a Debt to Total Capital ratio of 62.90%, a lower figure than the previous year's 149.66%.
Current ratio0.6973
Quick ratio0.5614
Total debt/total equity1.69
Total debt/total capital0.629
More ▼

Growth rates in GBP

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 320.00% and 209.51%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Healthcare Facilities industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked the highest relative to its industry peers.
Div yield(5 year avg)0.39%
Div growth rate (5 year)-11.18%
Payout ratio (TTM)28.62%
EPS growth(5 years)205.09
EPS (TTM) vs
TTM 1 year ago
38.67
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.